July-September 2022

Volume 1, Issue 1

First published: 16 June, 2022

Total of 12 Group 2 and 6 Group 3 CPD credits available

CPD is available to College members only. To become a member of the College click here

Features

Exploring roles for pharmacists in pain management

By Karalyn Huxhagen B Pharm FPS AACPA MACP, Professional Practice Pharmacist, Australasian College of Pharmacy

In 2019, as part of the National Strategic Action Plan for Pain Management, it was identified that there was ‘a need to improve the contemporary, evidence-based pain management related knowledge and skills of health practitioners’. This follow-up to the strategic plan is an opportunity to use learnings from trials such as the Chronic Pain MedsCheck trial to enable pharmacy in every setting to use change management strategies to move to participating in a multidisciplinary team environment and provide improved patient outcomes for patients living with pain. Read more

Monkeypox: What pharmacists need to know

By Dr Sonal Patel, BPharm, PhD, GCPH, MACP, Professional Practice Pharmacist, Australasian College of Pharmacy

Lack of reliable information and uncertainty are major contributors to community concern and anxiety about disease outbreaks. Pharmacists have an important role to play in raising awareness about what monkeypox is, who is at risk and how to prevent the spread of the virus. Read more

CPD - Clinical reviews

Epilepsy in childhood

By Kayla Lee BPharmSci, MPharm, Pharmacist & Managing Partner, Capital Chemist Braidwood

2 Group 2 CPD credits

The management of childhood epilepsy has many implications for the child, which potentially extend into adulthood. This article tracks these implications via a case study and outlines the stages pharmacists are involved in therapy including monitoring of antiepileptic drugs and their potential adverse outcomes. Read more

he human cutaneous microbiome

By Dr Brett MacFarlane BPharm Hons PhD FACP, Chief Pharmacist, Australasian College of Pharmacy

2 Group 2 CPD credits

Pharmacists are familiar with regimens for treating skin disease by controlling microbial infection. This CPD activity sheds light on the current knowledge of the role of microbes in chronic skin disease to help pharmacists better understand their causes and treatment. Read more

SGLT2 inhibitors for diabetes, renal disease, and heart failure

By Karalyn Huxhagen B Pharm FPS AACPA MACP, Professional Practice Pharmacist, Australasian College of Pharmacy

New indications for dapagliflozin means that pharmacists will see patients prescribed it for renal disease and heart failure as well as diabetes. Pharmacists need to be upskilled about the place in therapy of SGLT2 inhibitors for diabetes as well as the new indications. Read more

2 Group 2 CPD credits OR 6 Group 3 CPD credits

Urinary tract infections in adults: An overview

By Katherine Radnedge BPharm, Community pharmacist

2 Group 2 CPD credits

The potentially expanding role of pharmacists in the management of uncomplicated urinary tract infection means they must fully understand the sometimes challenging nature of UTI diagnosis and management and should take every opportunity to educate patients on the judicious use of antibiotics. Read more

CPD - Leadership and management reviews

Professionalism and accountability in pharmacy

By Emeritus Professor Greg Whateley, Dr Dimitri Kopanakis, and Dr Brett MacFarlane

2 Group 2 CPD credits

Pharmacists are members of a profession and hence are professionals who should demonstrate professionalism. This article outlines what it means to be a professional and how professionalism and accountability are cornerstones of the practice of pharmacy. Read more

Social Pharmacy: What is it and how is it relevant to pharmacy practice?

By Dr Sonal Patel, BPharm, PhD, GCPH, MACP, Professional Practice Pharmacist, Australasian College of Pharmacy

2 Group 2 CPD credits

Although the concept of social pharmacy is embedded within academia and research, frontline pharmacists can contribute to addressing the social determinants of health at a patient, practice, and community level. This article will describe social pharmacy, the importance of social pharmacy and how social pharmacy can be applied in practice. Read more

Pharmacy practice briefs

HIV self-testing

By Heath Paynter, Deputy Chief Executive Officer at AFAO (Australian Federation of AIDS organisations), the national peak organisation for the Australian community-controlled HIV response.

TGA regulatory changes in October 2021 mean that pharmacies can now sell the Atomo HIV Self-test. This represents an opportunity for pharmacies to provide a vital service and facilitate increased frequency of HIV testing within their communities. Read more

Japanese encephalitis

By Professor John S Mackenzie, AO, PhD, FTSE

By the end of April 2022, 37 human cases of Japanese encephalitis virus (JEV) had been reported in 4 Australian states. These are the first locally-acquired cases detected on the Australian mainland since 1998. Pharmacists need to be aware of the signs and symptoms of JEV so they can advise patients to seek further advice. CPD accredited webcast on JEV also available. Read more

The lowdown on the 4 psychological factors that help predict and explain employee behaviours

By Rebekah Radulovich, National Training and Development Manager - Defence Force Recruiting

This is an excerpt from the College CPD accredited article: “Part 1 - Organisational Behaviour: an introduction” designed to help pharmacists and managers understand how people behave within an organisation. Read more

Case study

Rosacea

By Dr Brett MacFarlane BPharm Hons PhD FACP, Chief Pharmacist, Australasian College of Pharmacy

This case study practically demonstrates how pharmacists should think differently about adults presenting with acne-like skin eruptions, and covers the simple steps that can be taken to manage rosacea. Read more